QFNHF
Qfin Holdings, Inc.
No data for this timeframe.
Vol
SEC Reports4
Recent Activity
Jun 3, 2026
SEC
Qfin Holdings reported the resignation of board member Dan Zhao for personal reasons, effective June 3, 2026, reducing t
6-K — Impact 2/10
May 12, 2026
SEC
Qfin Holdings filed a 6-K announcing its annual general meeting on June 30, 2026, with the sole agenda to re-appoint Del
6-K — Impact 1/10
Apr 28, 2026
SEC
Qfin Holdings filed two 6-Ks on April 27, 2026: one announcing the publication of its 2025 ESG report (a routine non-fin
6-K — Impact 2/10
Analyst Ratings
6Strong Buy
10Buy
3Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
6-K
2/10
Qfin Holdings reported the resignation of board member Dan Zhao for personal reasons, effective June 3, 2026, reducing t
Jun 3, 2026
NEUTRAL
6-K
1/10
Qfin Holdings filed a 6-K announcing its annual general meeting on June 30, 2026, with the sole agenda to re-appoint Del
May 12, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 1 mixed, 3 neutral. Avg impact: 2.5/10.
NEUTRAL
6-K
2/10
Qfin Holdings reported the resignation of board member Dan Zhao for personal reasons, effective June
Jun 3, 2026
NEUTRAL
6-K
1/10
Qfin Holdings filed a 6-K announcing its annual general meeting on June 30, 2026, with the sole agen
May 12, 2026
NEUTRAL
6-K
2/10
Qfin Holdings filed two 6-Ks on April 27, 2026: one announcing the publication of its 2025 ESG repor
Apr 28, 2026
MIXED
20-F
5/10
Qfin Holdings reported 2025 net revenue of RMB19.2B (up ~12% YoY) but net income attributable to sha
Apr 27, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 84% buy across 19 analysts — 6 strong buy, 10 buy, 3 hold, 0 sell, 0 strong sell. No current recommendation available.
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 6 | 10 | 3 | 0 | 0 | 84% | |
| May 1, 2026 | 7 | 10 | 2 | 0 | 0 | 89% | |
| Apr 1, 2026 | 7 | 10 | 2 | 0 | 0 | 89% | |
| Mar 1, 2026 | 7 | 10 | 2 | 0 | 0 | 89% | |
| Feb 1, 2026 | 7 | 10 | 2 | 0 | 0 | 89% | |
| Jan 1, 2026 | 7 | 10 | 2 | 0 | 0 | 89% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.